Ainos Inc AIMD 深 沪
等待开盘 04-01 09:30:00 美东时间
1.39
+0.040
+2.96%
华盛通- 最 高1.4312
- 今 开1.33
- 成交量 1.50万股
- 最 低 1.3134
- 昨 收 1.35
- 总市值 1009.98万
- 52周最高 4.4999
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 1.26
- 委 比 9.09%
- 总股本 726.60万
- 历史最高 93.75
- 量 比 0.63
- 振 幅 8.73%
- 历史最低 1.26
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ainos Q4 EPS $(0.85) Up From $(1.30) YoY, Sales $11.120K
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.85) per share. This is a 34.62 percent increase over losses of $(1.30) per share from the same period last year. The company reported $11.120 thousand in sales this
03-31 06:12
Ainos FY25 net loss narrows 0.6% to $14.8 million
Ainos FY25 net loss narrows 0.6% to $14.8 million Ainos posted a net loss of USD 15 million for 2025. Revenue jumped 499% to USD 124,157, mainly reflecting progress in AI Nose commercialization. Gross margin turned positive to 82.9%. Early-stage AI Nose deployments launched in semiconductor environm
03-30 21:05
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26 Ainos said it plans to deploy about 200 AI Nose systems in front-end wafer fabrication facilities in 1Q26. The company said Phase 1 of its agreement with ASE covers 1,400 AI Nose systems and is targeted for completion in 2Q26. Ainos
03-12 20:31
12 Information Technology Stocks Moving In Monday's After-Market Session
Gainers PicoCELA (NASDAQ:PCLA) stock moved upwards by 10.2% to $2.81 during Mo...
03-10 05:05
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal Ainos Inc. said it has a confirmed initial order for 1,400 AI Nose systems, which the company said will activate recurring subscription revenue under a three-year service structure totaling about $2.1 million.
03-02 21:30
Ainos shares are trading lower. The company announced interim results from its ongoing multi-dose clinical trial evaluating VELDONA for the treatment of Feline Chronic Gingivostomatitis.
Ainos shares are trading lower. The company announced interim results from its ...
02-18 01:41
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial Ainos Inc. announced interim results from an ongoing open-label, multi-dose clinical trial evaluating VELDONA, a low-dose oral interferon alpha formulation, for the treatment of Feline Chronic Gingivostomatitis (FC
02-17 21:01
Ainos Launches Live AI Nose Deployments Under $2.1 Million Semiconductor Order
Ainos Launches Live AI Nose Deployments Under $2.1 Million Semiconductor Order Ainos Inc. has begun live deployments of its AI Nose platform as part of a $2.1 million initial order from a leading semiconductor packaging and testing company. These back-end deployments mark the company's first commerc
02-09 21:01
Ainos Collaborates With Mirle Automation To Integrate Ainos' AI Platform Into Robots, Quadruped Robots
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced a technology partnership with Mirle
02-02 21:14
Ainos Partners with Mirle Automation to Bring Scent Intelligence to Robots
Ainos Partners with Mirle Automation to Bring Scent Intelligence to Robots Ainos Inc., a SmellTech platform company specializing in digitizing scent for artificial intelligence, has announced a technology partnership with Mirle Automation Corporation. The collaboration aims to integrate Ainos' AI No
02-02 21:01
